Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Karlsen

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Journal of Medicinal Chemistry|October 25, 2008
Discovery of potent and selective agonists for the free fatty acid receptor 1 (FFA(1)/GPR40), a potential target for the treatment of type II diabetesElisabeth Christiansen, Christian Urban, Nicole Merten, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Structure-Activity Study of Dihydrocinnamic Acids and Discovery of the Potent FFA1 (GPR40) Agonist TUG-469Elisabeth Christiansen, Maria E Due-Hansen, Christian Urban, et al.
Acta Obstetricia Et Gynecologica Scandinavica|September 1, 2021
SARS-CoV-2 infection in pregnancy in Denmark-characteristics and outcomes after confirmed infection in pregnancy: A nationwide, prospective, population-based cohort studyAnna J M Aabakke, Lone Krebs, Tanja G Petersen, et al.
Acta Obstetricia Et Gynecologica Scandinavica|January 25, 2023
Risk factors for and pregnancy outcomes after SARS-CoV-2 in pregnancy according to disease severity: A nationwide cohort study with validation of the SARS-CoV-2 diagnosisAnna J M Aabakke, Tanja G Petersen, Karen Wøjdemann, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Journal of Medicinal Chemistry|October 25, 2008
Discovery of potent and selective agonists for the free fatty acid receptor 1 (FFA(1)/GPR40), a potential target for the treatment of type II diabetesElisabeth Christiansen, Christian Urban, Nicole Merten, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Structure-Activity Study of Dihydrocinnamic Acids and Discovery of the Potent FFA1 (GPR40) Agonist TUG-469Elisabeth Christiansen, Maria E Due-Hansen, Christian Urban, et al.
Acta Obstetricia Et Gynecologica Scandinavica|September 1, 2021
SARS-CoV-2 infection in pregnancy in Denmark-characteristics and outcomes after confirmed infection in pregnancy: A nationwide, prospective, population-based cohort studyAnna J M Aabakke, Lone Krebs, Tanja G Petersen, et al.
Acta Obstetricia Et Gynecologica Scandinavica|January 25, 2023
Risk factors for and pregnancy outcomes after SARS-CoV-2 in pregnancy according to disease severity: A nationwide cohort study with validation of the SARS-CoV-2 diagnosisAnna J M Aabakke, Tanja G Petersen, Karen Wøjdemann, et al.
Pageof 5